Elevance Health Inc (ELV) Stock: Understanding the Volatility

In the past week, ELV stock has gone down by -2.18%, with a monthly gain of 0.02% and a quarterly surge of 5.87%. The volatility ratio for the week is 1.23%, and the volatility levels for the last 30 days are 1.34% for Elevance Health Inc. The simple moving average for the past 20 days is -2.21% for ELV’s stock, with a 6.34% simple moving average for the past 200 days.

Is It Worth Investing in Elevance Health Inc (NYSE: ELV) Right Now?

The price-to-earnings ratio for Elevance Health Inc (NYSE: ELV) is 19.83x, which is above its average ratio. Moreover, the 36-month beta value for ELV is 0.81. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The public float for ELV is 231.50M and currently, short sellers hold a 1.01% of that float. On April 03, 2024, ELV’s average trading volume was 1.02M shares.

ELV) stock’s latest price update

Elevance Health Inc (NYSE: ELV)’s stock price has dropped by -3.25 in relation to previous closing price of 516.00. Nevertheless, the company has seen a loss of -2.18% in its stock price over the last five trading days. CNBC Television reported 2024-04-02 that CNBC’s Bertha Coombs reports on what’s driving health insurer stocks lower.

Analysts’ Opinion of ELV

Many brokerage firms have already submitted their reports for ELV stocks, with Barclays repeating the rating for ELV by listing it as a “Overweight.” The predicted price for ELV in the upcoming period, according to Barclays is $584 based on the research report published on March 06, 2024 of the current year 2024.

Morgan Stanley gave a rating of “Overweight” to ELV, setting the target price at $571 in the report published on April 27th of the previous year.

ELV Trading at -0.59% from the 50-Day Moving Average

After a stumble in the market that brought ELV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -4.21% of loss for the given period.

Volatility was left at 1.34%, however, over the last 30 days, the volatility rate increased by 1.23%, as shares sank -1.02% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.45% upper at present.

During the last 5 trading sessions, ELV fell by -2.18%, which changed the moving average for the period of 200-days by +14.41% in comparison to the 20-day moving average, which settled at $510.22. In addition, Elevance Health Inc saw 5.87% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ELV starting from Kendrick Charles Morgan JR, who sale 2,432 shares at the price of $500.46 back on Mar 08 ’24. After this action, Kendrick Charles Morgan JR now owns 15,840 shares of Elevance Health Inc, valued at $1,217,119 using the latest closing price.

Penczek Ronald W, the CAO & Controller of Elevance Health Inc, sale 916 shares at $504.58 during a trade that took place back on Mar 06 ’24, which means that Penczek Ronald W is holding 1,764 shares at $462,195 based on the most recent closing price.

Stock Fundamentals for ELV

Current profitability levels for the company are sitting at:

  • 0.04 for the present operating margin
  • 0.9 for the gross margin

The net margin for Elevance Health Inc stands at 0.03. The total capital return value is set at 0.1. Equity return is now at value 15.84, with 5.66 for asset returns.

Based on Elevance Health Inc (ELV), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at 0.32. The debt to equity ratio resting at 0.64. The interest coverage ratio of the stock is 6.54.

Currently, EBITDA for the company is 1.74 billion with net debt to EBITDA at 2.19. When we switch over and look at the enterprise to sales, we see a ratio of 0.79. The receivables turnover for the company is 9.59for trailing twelve months and the total asset turnover is 1.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.44.


To wrap up, the performance of Elevance Health Inc (ELV) has been better in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts